In this section
The Regional Outreach and Shared Care Program (ROSCP) is a program that facilitates the transition between the primary treating hospital and the regional centres caring for children and adolescents with cancer. The program provides opportunities for shared care and ensures there are agreed levels of training and standards of care for medical, nursing, allied health and supportive services. This program is supported by the Sporting Chance Cancer Foundation.
The Long Term Follow-up Program (LTFP) facilitates the transition from completion of curative treatment to the ‘survivorship’ phase of the cancer journey. The aim of the program is to provide a clear and consistent standard of long term follow-up care across Victoria, which is responsive to the needs of all childhood cancer survivors and their families.
The program is accessible to all paediatric, adolescent and young adult survivors of childhood cancer living in Victoria. It provides each individual with a tailored approach to meet their ongoing needs and an appropriate transition plan to adult-based, community or hospital services. The PICS LTFP clinics are held at the Royal Children’s Hospital, Monash Children’s Hospital, Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Alfred Health and at designated regional centres.
The first bone marrow transplant performed at RCH was in
1973, and the formal transplant program; now known as the Haematopoietic Stem
Cell Transplant (HSCT) program, was commenced in 1981.
The program is responsible
for the clinical management, collection, processing, and administration of
haematopoietic progenitor cells (HPC) for allogeneic transplant or autologous
re-infusion of paediatric patients under the management of the Clinical Program
Director (Head of HSCT Program).
The HSCT program consists of defined operational teams with
trained staff working at the RCH that function as a single program; this includes
the following departments:
In addition to the hospital compliance with national standards in healthcare (ACHS EQuIP),
the HSCT program is certified by Australian
Bone Marrow Donor Registry (ABMDR).
The HSCT program is also
a member of the Australian and New Zealand Children's Haematology/Oncology
Group (ANZCHOG), which is the national multi-disciplinary group for paediatric
blood diseases and cancer.